These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 23701136)

  • 41. Designing multivalent proteins based on natural killer cell receptors and their ligands as immunotherapy for cancer.
    Smits NC; Coupet TA; Godbersen C; Sentman CL
    Expert Opin Biol Ther; 2016 Sep; 16(9):1105-12. PubMed ID: 27248342
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH; Berg SF; Vaage JT; Wang LL; Yokoyama WM; Dissen E; Fossum S
    J Leukoc Biol; 2004 Dec; 76(6):1200-6. PubMed ID: 15356098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The stage dependent changes in NK cell activity and the expression of activating and inhibitory NK cell receptors in melanoma patients.
    Mirjačić Martinović K; Konjević G; Babović N; Inić M
    J Surg Res; 2011 Dec; 171(2):637-49. PubMed ID: 20828749
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Activating and inhibitory receptors of natural killer cells.
    Pegram HJ; Andrews DM; Smyth MJ; Darcy PK; Kershaw MH
    Immunol Cell Biol; 2011 Feb; 89(2):216-24. PubMed ID: 20567250
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model.
    Swift BE; Williams BA; Kosaka Y; Wang XH; Medin JA; Viswanathan S; Martinez-Lopez J; Keating A
    Haematologica; 2012 Jul; 97(7):1020-8. PubMed ID: 22271890
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential expression of natural killer cell activating receptors in blood versus bone marrow in patients with monoclonal gammopathy.
    Costello RT; Boehrer A; Sanchez C; Mercier D; Baier C; Le Treut T; Sébahoun G
    Immunology; 2013 Jul; 139(3):338-41. PubMed ID: 23360454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions.
    Jung D; Baek YS; Lee IJ; Kim KY; Jang H; Hwang S; Jung J; Moon YW; Park KS; Choi YS; An HJ
    J Exp Clin Cancer Res; 2021 Oct; 40(1):333. PubMed ID: 34686187
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Human natural killer receptors, co-receptors, and their ligands.
    Biassoni R
    Curr Protoc Immunol; 2009 Feb; Chapter 14():14.10.1-14.10.40. PubMed ID: 19235767
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of total flavonoids from the seeds of Astragali complanati on natural killer cell function.
    Han R; Wu WQ; Wu XP; Liu CY
    J Ethnopharmacol; 2015 Sep; 173():157-65. PubMed ID: 26196400
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of chemotherapy/radiotherapy on cancerous pattern recognition by NK cells.
    Rosental B; Appel MY; Yossef R; Hadad U; Brusilovsky M; Porgador A
    Curr Med Chem; 2012; 19(12):1780-91. PubMed ID: 22414084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function.
    Tremblay-McLean A; Coenraads S; Kiani Z; Dupuy FP; Bernard NF
    BMC Immunol; 2019 Jan; 20(1):8. PubMed ID: 30696399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Balancing natural killer cell activation through paired receptors.
    Martinet L; Smyth MJ
    Nat Rev Immunol; 2015 Apr; 15(4):243-54. PubMed ID: 25743219
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural killer cells control metastasis via structural editing of primary tumors in mice.
    Isaacson B; Mandelboim O
    Cancer Immunol Immunother; 2019 Oct; 68(10):1721-1724. PubMed ID: 31606778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunotherapeutic targeting of activating natural killer cell receptors and their ligands in cancer.
    Peipp M; Klausz K; Boje AS; Zeller T; Zielonka S; Kellner C
    Clin Exp Immunol; 2022 Jul; 209(1):22-32. PubMed ID: 35325068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetically coupled receptor-ligand pair NKp80-AICL enables autonomous control of human NK cell responses.
    Klimosch SN; Bartel Y; Wiemann S; Steinle A
    Blood; 2013 Oct; 122(14):2380-9. PubMed ID: 23929856
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of C-type lectin-like receptors NKp65 and KACL facilitates dedicated immune recognition of human keratinocytes.
    Spreu J; Kuttruff S; Stejfova V; Dennehy KM; Schittek B; Steinle A
    Proc Natl Acad Sci U S A; 2010 Mar; 107(11):5100-5. PubMed ID: 20194751
    [TBL] [Abstract][Full Text] [Related]  

  • 57. How to trigger a killer: modulation of natural killer cell reactivity on many levels.
    Watzl C
    Adv Immunol; 2014; 124():137-70. PubMed ID: 25175775
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity.
    Castriconi R; Dondero A; Negri F; Bellora F; Nozza P; Carnemolla B; Raso A; Moretta L; Moretta A; Bottino C
    Eur J Immunol; 2007 Nov; 37(11):3190-6. PubMed ID: 17918205
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Research Progress on NK Cell Receptors and Their Signaling Pathways.
    Chen Y; Lu D; Churov A; Fu R
    Mediators Inflamm; 2020; 2020():6437057. PubMed ID: 32774149
    [TBL] [Abstract][Full Text] [Related]  

  • 60. NK cell recognition of unconventional ligands.
    Huntington ND
    Immunol Cell Biol; 2014 Mar; 92(3):208-9. PubMed ID: 24638097
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.